Paid Clinical Trials and Focus Groups by Category |
|
|
|
Condition: Fibromyalgia
Intervention: Drug: Duloxetine
Sponsor: Eli Lilly and Company
Not yet recruiting - verified March 2010
Condition: Acute Coronary Syndrome
Intervention: Drug: ADP receptor inhibitors
Sponsors: Eli Lilly and Company; Daiichi Sankyo Inc.
Recruiting - verified March 2010
Condition: Diabetic Neuropathy, Painful
Interventions: Drug: Duloxetine; Drug: Pregabalin; Drug: Placebo
Sponsors: Eli Lilly and Company; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Condition: Schizophrenia
Intervention:
Sponsor: Eli Lilly and Company
Enrolling by invitation - verified March 2010
Condition: Head and Neck Neoplasms
Interventions: Drug: Pemetrexed; Drug: Cetuximab; Drug: Carboplatin; Drug: Cisplatin
Sponsor: Eli Lilly and Company
Not yet recruiting - verified March 2010
Condition: Schizophrenia
Interventions: Drug: Risperidone; Drug: Placebo; Drug: LY2140023
Sponsor: Eli Lilly and Company
Not yet recruiting - verified March 2010
Condition: Head and Neck Cancer
Interventions: Drug: cetuximab; Drug: Cisplatin; Drug: Carboplatin; Drug: 5-fluorouracil
Sponsor: Eli Lilly and Company
Not yet recruiting - verified March 2010
Condition: Osteoporosis
Intervention: Drug: FORTEO
Sponsor: Eli Lilly and Company
Active, not recruiting - verified March 2010
Condition: Head and Neck Cancer
Intervention: Other: Therapy for head and neck cancer
Sponsor: Eli Lilly and Company
Recruiting - verified March 2010
Conditions: Hypopituitarism; Pituitary Insufficiency; Growth Hormone Deficiency, Adult
Intervention: Drug: Somatropin (rDNA origin)
Sponsor: Eli Lilly and Company
Enrolling by invitation - verified March 2010
Conditions: Dwarfism, Growth Hormone Deficiency; Turner Syndrome; Infant, Small for Gestational Age; SHOX Protein, Human
Intervention: Drug: Somatropin (rDNA origin)
Sponsor: Eli Lilly and Company
Enrolling by invitation - verified March 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Insulin Glargine; Drug: LY2189265
Sponsor: Eli Lilly and Company
Recruiting - verified March 2010
Condition: Infection
Interventions: Drug: Cephalexin capsules (Optocef, BAY o5448 ); Drug: Cephalexin capsules (Keflex)
Sponsors: Bayer; Corporación Bonima S.A. de C.V.
Completed - verified February 2010
Condition: Infection
Interventions: Drug: Cephalexin suspension (Optocef, BAYO5448); Drug: Cephalexin suspension (Keflex)
Sponsors: Bayer; Corporación Bonima S.A. de C.V.
Completed - verified February 2010
Condition: Pregnancy
Intervention: Drug: duloxetine
Sponsors: Eli Lilly and Company; Kendle International
Recruiting - verified February 2010
Condition: Type 2 Diabetes
Interventions: Drug: exenatide; Drug: Other antidiabetic therapies; Other: No diabetes therapy
Sponsors: Amylin Pharmaceuticals, Inc.; Eli Lilly and Company
Completed - verified February 2010